ADC Therapeutics S.A.
ADCT | NYSE
$1.12
$0 (0.00%)
Sep 22, 2026, 9:37 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 81.36M | 70.84M | 69.56M | 209.91M | 33.92M | n/a |
Cost of Revenue | 7.67M | 5.95M | 2.53M | 3.3M | 1.39M | 141.82M |
Gross Profit | 73.68M | 64.89M | 67.03M | 206.61M | 32.52M | -141.82M |
Operating Income | -108.38M | -130.65M | -165.99M | -123.34M | -261.72M | -219.26M |
Interest Income | 8.81M | 12.27M | 10.54M | 2.57M | 66K | 832K |
Pretax Income | -142.78M | -157.68M | -200.95M | -156.9M | -251.51M | -245.96M |
Net Income | -142.62M | -157.85M | -240.05M | -157.13M | -230.03M | -246.29M |
Selling & General & Admin | -6.82M | 85.91M | 105.89M | 143.49M | 136.24M | 77.23M |
Research & Development | 104.01M | 109.63M | 127.13M | 186.46M | 158M | 142.03M |
Other Expenses | 84.87M | n/a | n/a | n/a | n/a | -141.82M |
Operating Expenses | 182.06M | 195.54M | 233.02M | 329.95M | 294.24M | 77.45M |
Interest Expense | 51.63M | 50.21M | 46.33M | 36.73M | 18.34M | 4.93M |
Selling & Marketing Expenses | -43.37M | 21.44M | 33.01M | 35.75M | 64.78M | 22.1M |
Cost & Expenses | 189.74M | 201.49M | 235.54M | 333.25M | 295.64M | 219.26M |
Income Tax Expense | -157K | 166K | 39.11M | 227K | -21.48M | 327K |
Shares Outstanding (Basic) | 127.07M | 97.16M | 81.71M | 78.15M | 76.75M | 65.41M |
Shares Outstanding (Diluted) | 127.07M | 97.16M | 81.71M | 78.15M | 76.75M | 65.41M |
EPS (Basic) | -1.12 | -1.62 | -2.94 | -1.99 | -3 | -3.77 |
EPS (Diluted) | -1.12 | -1.62 | -2.94 | -1.99 | -3 | -3.77 |
EBITDA | -89.27M | -102.65M | -145.83M | -107.7M | -230.54M | -218.23M |
EBIT | -91.15M | -105.93M | -149.09M | -110.09M | -233.17M | -219.05M |
Depreciation & Amortization | 1.88M | 3.28M | 3.27M | 2.39M | 2.63M | 821K |
Add to Watchlist
Select watchlists to add or remove ADCT